Private Equity Portfolio Company
NTC
Milan
Italy
https://www.ntcpharma.com
NTC develops, produces and distributes niche prescription drugs, OTC drugs, medical devices and innovative food supplements. Add-on Acquisition: - Ophthalmic product portfolio: Colircusi Gentadexa (aminoglycoside), Colircusi Gentamicin and ...
Private Equity Owner: Wise Equity SGR
Acquisition Criteria
Investment Date:
Exit Date:
Status:
Add-on Acquisitions:
Industry (NAICS Code):
Testimonials
Become the next customer to share a success story about Private Equity Info's impact.
"Private Equity Info is critical to nearly every aspect of our role as an investment bank. We use it almost every day and the return on investment is clear."
Bob McCormack
"PEI is superior for our sales team. It cuts to the core. It’s the sweet spot in terms of what you’re paying and what you’re getting.”
